These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35689497)

  • 1. Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice.
    Reymundo A; Vilarrasa E; Baniandrés O; Rodríguez-Fernández-Freire L; Feltes R; Llamas-Velasco M; Daudén E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e849-e851. PubMed ID: 35689497
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study.
    Ruan SF; Zhang LL; Liu Z; Lin TT; Wang HQ; Xu QY; Xiang N; Cheng B; Liu T; Ha HY; Gong T; Ji C
    J Am Acad Dermatol; 2023 Jan; 88(1):243-246. PubMed ID: 35588923
    [No Abstract]   [Full Text] [Related]  

  • 3. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    Miao C; Chen Y; Wang Z; Xiang X; Liu Y; Xu Z
    J Dermatol; 2023 Feb; 50(2):258-261. PubMed ID: 35983654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of generalized pustular psoriasis with secukinumab: a report of two cases.
    Sun ZL; Liu ZL; Xu YY; Zhang XL; Zhang CL; Guan X
    Chin Med J (Engl); 2020 Nov; 133(24):3015-3016. PubMed ID: 33237694
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid and sustained response of acute generalized pustular psoriasis of von Zumbusch to Secukinumab.
    Wu X; Yan T; Han C; Ma L; Zeng L; Chen X; Zhang Z
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e338-e341. PubMed ID: 36165592
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrence of secukinumab-induced eczematous eruptions after guselkumab treatment for pustular psoriasis.
    Miyagawa F; Fukuda K; Mori A; Ogawa K; Asada H
    J Dermatol; 2021 Oct; 48(10):E498-E499. PubMed ID: 34212414
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcriptomic response of peripheral blood mononuclear cells to secukinumab in an 8-year-old boy with juvenile generalized pustular psoriasis.
    Hou PC; Aala W; Lee YR; Guevara BEK; Chen PC; McGrath JA; Hsu CK
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e378-e381. PubMed ID: 35023595
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report.
    Liu N; Zhu L; Cheng Y; Yu N; Yi X; Ding Y
    Acta Derm Venereol; 2020 Aug; 100(15):adv00251. PubMed ID: 32812054
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series.
    Albela H; Begum S; Leong KF
    J Dermatolog Treat; 2022 May; 33(3):1769-1773. PubMed ID: 33706651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis.
    Ito M; Kamata M; Uchida H; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Tada Y
    Br J Dermatol; 2022 Nov; 187(5):793-795. PubMed ID: 35661135
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
    Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of generalized pustular psoriasis with discrepant resolution time between pustules and erythema after treatment with spesolimab.
    Matsuo M; Niwa H; Onishi H; Iwata H
    J Dermatol; 2024 Apr; 51(4):e127-e128. PubMed ID: 37955351
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized pustular psoriasis treated with ustekinumab.
    Storan ER; O'Gorman SM; Markham T
    Clin Exp Dermatol; 2016 Aug; 41(6):689-90. PubMed ID: 27333948
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient.
    Megna M; Abategiovanni L; Annunziata A; Torta G; Peduto T; Fabbrocini G; Lauro W
    Dermatol Ther; 2022 May; 35(5):e15382. PubMed ID: 35170168
    [No Abstract]   [Full Text] [Related]  

  • 15. De novo pustular psoriasis associated with dupilumab therapy in a young male with the diagnosis of atopic dermatitis.
    Incel Uysal P; Gunhan O
    Dermatol Ther; 2022 May; 35(5):e15399. PubMed ID: 35194901
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized pustular psoriasis recurring during pregnancy and lactation successfully treated with ixekizumab.
    Huang D; Liu T; Li J; Lu Y; Ma H
    Dermatol Ther; 2022 Dec; 35(12):e15878. PubMed ID: 36181408
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
    Minai L; Takeichi T; Ogawa Y; Honobe-Tabuchi A; Okamoto T; Mitsui H; Shimada S; Akiyama M; Kawamura T
    J Dermatol; 2023 Feb; 50(2):245-249. PubMed ID: 36052669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of treatments for generalized pustular psoriasis.
    Kearns DG; Chat VS; Zang PD; Han G; Wu JJ
    J Dermatolog Treat; 2021 Aug; 32(5):492-494. PubMed ID: 31697211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmoplantar pustulosis under secukinumab in two patients without psoriasis.
    Penalba-Torres M; Rivera-Díaz R
    J Dtsch Dermatol Ges; 2022 Jan; 20(1):106-109. PubMed ID: 34751502
    [No Abstract]   [Full Text] [Related]  

  • 20. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
    Reolid A; Armesto S; Sahuquillo-Torralba A; Torres T; Feltes R; Vilarrasa E; Belinchón I; Cueva P; Rodríguez L; Romero-Maté A; Vidal D; Coto-Segura P; Herrera-Acosta E; Riera-Monroig J; Salgado L; Llamas-Velasco M; Daudén E
    J Am Acad Dermatol; 2022 Sep; 87(3):705-709. PubMed ID: 35640798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.